CPL 001

Drug Profile

CPL 001

Alternative Names: CPL001

Latest Information Update: 22 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator University College London
  • Class Anti-infectives; Antibacterials; Small molecules
  • Mechanism of Action Enzyme inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Research Sepsis

Most Recent Events

  • 15 Nov 2017 Early research in Sepsis in United Kingdom (Parenteral) before November 2017
  • 15 Nov 2017 Critical Pressure plans a clinical trial for Sepsis in United Kingdom in early 2019
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top